| Factor Information | |
|---|---|
| Data ID | 1299 |
| Factor | lower BMI |
| Description | PPVI (Percutaneous pulmonary valve implantation) related VT (ventricular tachycardia) was detected in 6 patients (7.5%). These patients had a lower BMI (17.5±2.0 vs. 23.1±6.6, P=0.04). |
| Biomarker | NA |
| Classification | E11 (physiological factor - physical sign) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | To explore the correlation between the BMI and the occurance of PPVI related VT. |
| p Value | 0.04 |
| Conclusion | PPVI may be associated with transient VT in the acute peri-procedural period. Patients of smaller size may be more susceptible. All patients were managed conservatively and none of the patients had a recurrence, which is suggestive of a transient phenomenon. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 513 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | TOF/PA/RVOTO |
| Reference | |
|---|---|
| PMID | 27670128 |
| Year | 2016 |
| Title | Percutaneous Pulmonary Valve Implantation-Associated Ventricular Tachycardia in Congenital Heart Disease |
| Sample | ||
|---|---|---|
| Population | adolescents | |
| Source | N/A | |
| Region | Houston, United States | |
| Method | overnight telemetry monitoring | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | Percutaneous Pulmonary Valve Implantation | |
| Group | Acute VT(Treatment) | No Acute VT(Control) |
| Number | 6 | 73 |
| Age | 12.5±3.4 years | 17.9±8.9 years |
| Gender (Male: Female) | 3:3 | 47:26 |
| Marker Level | BMI: 17.5±2.0 | BMI: 23.1 ± 6.6 |
